A new KIR-CAR approach is trying to bring the engineered-cell revolution to solid tumours — but for now it looks more like a translational promise than a proven treatment
A new KIR-CAR approach is trying to bring the engineered-cell revolution to solid tumours — but for now it looks more like a translational promise than a proven treatment In recent years, CAR-based cell therapies have helped reshape treatment for som...
Continue reading







